Hong Kong SAR

The protests in Hong Kong continue to spiral out of control. Hundreds of thousands of people have taken to the streets. Residents have got used to the sight of armed response units running past their windows. The airport has ground to a halt. Was it really sensible to plan a business trip in the middle of all this?

China IT company Chinasoft International has returned to the syndicated loan market after six years, seeking a HK$1bn ($127m) facility.

The People’s Bank of China (PBoC) bagged Rmb30bn ($4.3bn) through a two tranche trade on Wednesday. It was not the first time the issuer picked a curious time to sell Bills.

Loans banker Daniel Chung is leaving Maybank Kim Eng to join CTBC Bank's Hong Kong team, according to sources.

A former co-head of Asia Pacific equity capital markets HSBC Alexis Adamczyk has started work at Far East Consortium International, just months after leaving the bank.

In this round-up, China warned Hong Kong’s Cathay Pacific Airways amid intensifying protests in the city, Hengfeng Bank received state backing after Baoshang and Jinzhou moves and the offshore Chinese market experienced the largest outflows since March

In this round-up, hostility between China and the US continued, the State Council unveiled rules on the Shanghai Free Trade Zone and Beijing said it would intervene if the Hong Kong government fails to calm down the recent unrest.

The Hong Kong, Shanghai and Shenzhen stock exchanges have agreed to include Hong Kong listed dual-class shares in the Stock Connect trading programme. This could just be what the HKEX’s two lonely weighted voting rights (WVRs) stocks, Xiaomi Corp and Meituan Dianping, need, said bankers and analysts. Jonathan Breen reports.

Rising tensions between the US and China, coupled with a mass strike in Hong Kong at the start of the week, caused a sell-off not just in the city’s stocks market but also across Asian bonds. While sentiment has recovered slowly, the market turbulence is set to keep equity and bond bankers on their toes. Jonathan Breen, Morgan Davis and Addison Gong report.

As a banker, it is always ideal to be the first in whatever we do.

Credit Suisse's head of Greater China debt capital markets has quit the bank, according to sources.

Chinese biotechnology company Venus Medtech (Huangzhou) is seeking approval to list in Hong Kong, having filed a draft prospectus with the city’s bourse on Monday.